233.87  3.42 (1.48%)		09-13 16:00
Open: 230.45 High: 234.705 Volume: 602,196		Pre. Close: 230.45 Low: 229.38 Market Cap: 16,398(M)

Short term
Mid term
Targets	6-month :	274.13	1-year :	320.19
Resists	First :	234.7	Second :	274.13
Pivot price	210.55
Supports	First :	196.57	Second :	173
MAs	MA(5) :	227.53	MA(20) :	205.08
	MA(100) :	191.84	MA(250) :	182.79
MACD	MACD :	9.7	Signal :	6.2
%K %D	K(14,3) :	96.8	D(3) :	96.5
RSI	RSI(14): 74
52-week	High :	234.7	Low :	125.81

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ PODD ] has closed below upper band by 12.5%. Bollinger Bands are 164.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 10 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	234.85 - 235.54	235.54 - 236.32
Low:	227.26 - 228.11	228.11 - 229.07
Close:	232.36 - 233.65	233.65 - 235.1

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.

Sat, 14 Sep 2024
Achmea Investment Management B.V. Takes $999,000 Position in Insulet Co. (NASDAQ:PODD) - MarketBeat

Fri, 13 Sep 2024
Jessica Hopfield At Insulet Decides to Exercises Options Worth $1.53M - Benzinga

Fri, 13 Sep 2024
A Look At The Intrinsic Value Of Insulet Corporation (NASDAQ:PODD) - Yahoo Finance

Fri, 13 Sep 2024
Insulet Corporation (NASDAQ:PODD) Q2 2024 Earnings Call Transcript - MSN

Tue, 10 Sep 2024
Insulet stock soars to 52-week high, reaches $223.65 - Investing.com

Mon, 09 Sep 2024
Is Insulet (NASDAQ:PODD) A Risky Investment? - Simply Wall St

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	70 (M)
Shares Float	70 (M)
Held by Insiders	0.3 (%)
Held by Institutions	101.8 (%)
Shares Short	2,830 (K)
Shares Short P.Month	2,970 (K)

EPS	5.53
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	14.23
Profit Margin	21.1 %
Operating Margin	11.1 %
Return on Assets (ttm)	6.8 %
Return on Equity (ttm)	50.9 %
Qtrly Rev. Growth	23.2 %
Gross Profit (p.s.)	0
Sales Per Share	26.66
EBITDA (p.s.)	5.19
Qtrly Earnings Growth	563.9 %
Operating Cash Flow	285 (M)
Levered Free Cash Flow	69 (M)

PE Ratio	42.29
PEG Ratio	4.5
Price to Book value	16.42
Price to Sales	8.76
Price to Cash Flow	57.47

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.